Bill Search

  • Introduced
    Feb 27, 2020
  • Passed House
  • Passed Senate
  • Signed into Law
HB 5366
Connecticut House Bill
AN ACT CONCERNING THE COST OF PRESCRIPTION DRUGS. To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.
Last Action
House • Mar 11, 2020: Filed with Legislative Commissioners' Office
Latest bill text

Official Summary/Bill Text

Comments on Bill

Tweets

Do you support this bill?
Yay Nay
Sponsors:
Votes
YES: 15
  • Lesser M.
  • Scanlon S.
  • Hartley J.
  • Dathan L.
  • Pavalock-D'Amato C.
  • Anwar S.
  • Bizzarro G.
  • Cassano S.
  • de la Cruz J.
  • Delnicki T.
  • Hughes A.
  • Polletta J.
  • Riley E.
  • Rosario C.
  • Turco G.

NO: 4
  • Kelly K.
  • Floren L.
  • O'Neill A.
  • Vail K.

ABSENT: 1
  • Nolan A.

Actions
  • Mar 11, 2020 | House
    • Filed with Legislative Commissioners' Office
  • Mar 10, 2020 | House
    • Joint Favorable Substitute
  • Feb 28, 2020 | House
    • Public Hearing 03/03
  • Feb 27, 2020 | House
    • Referred to Joint Committee on Insurance and Real Estate
Bill Texts